266 related articles for article (PubMed ID: 26826434)
1. Genetic factors and systemic sclerosis.
Murdaca G; Contatore M; Gulli R; Mandich P; Puppo F
Autoimmun Rev; 2016 May; 15(5):427-32. PubMed ID: 26826434
[TBL] [Abstract][Full Text] [Related]
2. Genetic implications in the pathogenesis of systemic sclerosis.
Rezaei R; Aslani S; Dashti N; Jamshidi A; Gharibdoost F; Mahmoudi M
Int J Rheum Dis; 2018 Aug; 21(8):1478-1486. PubMed ID: 30146749
[TBL] [Abstract][Full Text] [Related]
3. Epigenetics and systemic sclerosis.
Altorok N; Kahaleh B
Semin Immunopathol; 2015 Sep; 37(5):453-62. PubMed ID: 26162437
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic suppression of Fli1, a potential predisposing factor in the pathogenesis of systemic sclerosis.
Asano Y
Int J Biochem Cell Biol; 2015 Oct; 67():86-91. PubMed ID: 26055516
[TBL] [Abstract][Full Text] [Related]
5. Epigenetics: The Future Direction in Systemic Sclerosis.
Walczyk M; Paradowska-Gorycka A; Olesinska M
Scand J Immunol; 2017 Dec; 86(6):427-435. PubMed ID: 28930377
[TBL] [Abstract][Full Text] [Related]
6. Systemic sclerosis: genetics and epigenetics.
Luo Y; Wang Y; Wang Q; Xiao R; Lu Q
J Autoimmun; 2013 Mar; 41():161-7. PubMed ID: 23415078
[TBL] [Abstract][Full Text] [Related]
7. New insights into the genetics and epigenetics of systemic sclerosis.
Angiolilli C; Marut W; van der Kroef M; Chouri E; Reedquist KA; Radstake TRDJ
Nat Rev Rheumatol; 2018 Nov; 14(11):657-673. PubMed ID: 30305700
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis.
Noda S; Asano Y; Nishimura S; Taniguchi T; Fujiu K; Manabe I; Nakamura K; Yamashita T; Saigusa R; Akamata K; Takahashi T; Ichimura Y; Toyama T; Tsuruta D; Trojanowska M; Nagai R; Sato S
Nat Commun; 2014 Dec; 5():5797. PubMed ID: 25504335
[TBL] [Abstract][Full Text] [Related]
9. [A Uuifying hypothesis for the pathogenesis of systemic sclerosis based on the deficiency of transcription factor Fli1 - the development of a new animal model of systemic sclerosis -].
Asano Y
Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(6):475-87. PubMed ID: 25748132
[TBL] [Abstract][Full Text] [Related]
10. Genetic and epigenetic abnormalities in systemic sclerosis.
Makino T; Jinnin M
J Dermatol; 2016 Jan; 43(1):10-8. PubMed ID: 26782002
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic mechanisms: An emerging role in pathogenesis and its therapeutic potential in systemic sclerosis.
Luo Y; Wang Y; Shu Y; Lu Q; Xiao R
Int J Biochem Cell Biol; 2015 Oct; 67():92-100. PubMed ID: 26043891
[TBL] [Abstract][Full Text] [Related]
12. [Genetic basis of systemic sclerosis].
Yu J; Zuo YG; Sun QN
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Feb; 31(1):97-102. PubMed ID: 19317071
[TBL] [Abstract][Full Text] [Related]
13. Deciphering the genetic background of systemic sclerosis.
Broen JC; Coenen MJ; Radstake TR
Expert Rev Clin Immunol; 2011 Jul; 7(4):449-62. PubMed ID: 21790288
[TBL] [Abstract][Full Text] [Related]
14. Unfolding the pathogenesis of scleroderma through genomics and epigenomics.
Tsou PS; Sawalha AH
J Autoimmun; 2017 Sep; 83():73-94. PubMed ID: 28526340
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic factors as drivers of fibrosis in systemic sclerosis.
Bergmann C; Distler JH
Epigenomics; 2017 Apr; 9(4):463-477. PubMed ID: 28343418
[TBL] [Abstract][Full Text] [Related]
16. Epigenetics and pathogenesis of systemic sclerosis; the ins and outs.
Aslani S; Sobhani S; Gharibdoost F; Jamshidi A; Mahmoudi M
Hum Immunol; 2018 Mar; 79(3):178-187. PubMed ID: 29330110
[TBL] [Abstract][Full Text] [Related]
17. [Research progress in epigenetic studies on systemic sclerosis].
Long Y; Chen W; Du Q; Zuo X; Zhu H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 43(12):1369-1375. PubMed ID: 30643055
[TBL] [Abstract][Full Text] [Related]
18. B cells in systemic sclerosis: a possible target for therapy.
Bosello S; De Luca G; Tolusso B; Lama G; Angelucci C; Sica G; Ferraccioli G
Autoimmun Rev; 2011 Aug; 10(10):624-30. PubMed ID: 21545850
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes.
Matsushita T; Hasegawa M; Yanaba K; Kodera M; Takehara K; Sato S
Arthritis Rheum; 2006 Jan; 54(1):192-201. PubMed ID: 16385515
[TBL] [Abstract][Full Text] [Related]
20. Potential immunologic targets for treating fibrosis in systemic sclerosis: a review focused on leukocytes and cytokines.
Hasegawa M; Takehara K
Semin Arthritis Rheum; 2012 Dec; 42(3):281-96. PubMed ID: 22542279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
